Found 27 matching trials
Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer PHASE2 The AMALTHEA (Aflibercept MAintenance after first-Line THErapy with FOLFIRI...
Show More Location
Agios Georgios Chania General Hospital
Learn More & Join Trial
PERMAD: Personalized Marker-driven Early Switch to Aflibercept in Patients With Metastatic Colorectal Cancer PHASE2 The primary objective of the two phase PERMAD trial is the evaluation of th...
Show More Location
University Medical Center Hamburg-Eppendorf
Learn More & Join Trial
Folfiri/aflIbercept in Metastatic coloreCTal Cancer patIents With RAS Validated Wild typE Status NA The study will a be a biologically enriched, prospectively stratified phase...
Show More Location
A.O. Treviglio-Caravaggio, P.le Ospedale n1
Learn More & Join Trial
Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer PHASE1 The primary objective is to determine the dose of aflibercept to be further...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan PHASE2 Primary Objective:
To assess efficacy aflibercept + 5-fluorouracil (5-FU)/...
Show More Location
Investigational Site Number 392011
Learn More & Join Trial
Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen PHASE3 Primary Objective:
To provide metastatic colorectal cancer participants wi...
Show More Location
Investigational Site Number 840-002
Learn More & Join Trial
A Non-Interventional Follow-Up to the VELOUR Study - Translational Research N/A This is a follow-on study to the VELOUR trial (NCT00561470). The aim of thi...
Show More Location
Thomas Jefferson University Hospital
Learn More & Join Trial
Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer PHASE2 Immune chekpoints (ICI) are evaluated in many digestive cancers. Certain ty...
Show More Location
Ch - Centre Hospitalier D'Abbeville
Learn More & Join Trial
Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer N/A Colorectal cancer is the third most frequent neoplasm after prostate and lu...
Show More Location
SSD-Terapie Innovative Metastasi Addominali, Dipartimento di Oncologia Addominale, Istituto Nazionale Tumori di Napoli, IRCCS "G. Pascale".
Learn More & Join Trial
Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen PHASE3 The main objective of the study was to evaluate the effectiveness of aflibe...
Show More Location
Sanofi-Aventis Investigational Site Number 840119
Learn More & Join Trial